Full Text |
QUERY: Citation Author = "Muppalla, K." | MyPDB Login | Search API |
| Search Summary | This query matches 2 Structures. |
Structure Determination MethodologyScientific Name of Source OrganismTaxonomyExperimental MethodPolymer Entity TypeRefinement Resolution (Å)Release DateEnzyme Classification NameSymmetry TypeSCOP Classification | 1 to 2 of 2 Structures Page 1 of 1 Sort by 
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology(2018) Bioorg Med Chem Lett 28: 2029-2034
Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologyBoga, S.B., Deng, Y., Zhu, L., Nan, Y., Cooper, A., Shipps Jr., G.W., Doll, R., Shih, N., Zhu, H., Sun, R., Wang, T., Paliwal, S., Tsui, H., Gao, X., Yao, X., Desai, J., Wang, J., Alhassan, A.B., Kelly, J., Patel, M., Muppalla, K., Gudipati, S., Zhang, L., Buevich, A., Hesk, D., Carr, D., Dayananth, P., Mei, H., Cox, K., Sherborne, B., Hruza, A.W., Xiao, L., Jin, W., Long, B., Liu, G., Taylor, S.A., Kirschmeier, P., Windsor, W.T., Bishop, R., Samatar, A.A. (2018) ACS Med Chem Lett 9: 761-767
1 to 2 of 2 Structures Page 1 of 1 Sort by |
